Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
Cooper, David A
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. [electronic resource] - AIDS (London, England) Mar 2014 - 717-25 p. digital
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1473-5571
10.1097/QAD.0000000000000131 doi
Adolescent
Adult
Aged
Alkynes
Anti-HIV Agents--adverse effects
Antiretroviral Therapy, Highly Active--adverse effects
Benzoxazines--adverse effects
CD4 Lymphocyte Count
Cyclohexanes--adverse effects
Cyclopropanes
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
HIV Infections--drug therapy
HIV-1--isolation & purification
Humans
Male
Maraviroc
Middle Aged
Treatment Outcome
Triazoles--adverse effects
Viral Load
Young Adult
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. [electronic resource] - AIDS (London, England) Mar 2014 - 717-25 p. digital
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1473-5571
10.1097/QAD.0000000000000131 doi
Adolescent
Adult
Aged
Alkynes
Anti-HIV Agents--adverse effects
Antiretroviral Therapy, Highly Active--adverse effects
Benzoxazines--adverse effects
CD4 Lymphocyte Count
Cyclohexanes--adverse effects
Cyclopropanes
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
HIV Infections--drug therapy
HIV-1--isolation & purification
Humans
Male
Maraviroc
Middle Aged
Treatment Outcome
Triazoles--adverse effects
Viral Load
Young Adult